HEREDITARY ANGIONEUROTIC EDEMA AND PREGNANCY. A CASE REPORT
Journal Title: European Journal of Pharmaceutical and Medical Research - Year 2019, Vol 6, Issue 5
Abstract
Hereditary angioneurotic edema (HAO) is the clinical translation of C1 esterase inhibitor deficiency (C1 INH). The frequency and severity of clinical manifestation are extremely variable, ranging from edema of moderate extremes to obstruction of the upper airways. The natural history of HAO during the pregnancy is unpredictable. The hormonal impregnation, the trauma of the childbirth appear factors susceptible to activate the crises. We report a case of OAH and pregnancy. Through this case as well as a revue of the literature, we are going to try to identify the clinical manifestations of this rare affection during the pregnancy and in post-partum as well as the various modalities of therapeutic coverage.
Authors and Affiliations
M. Mehdi Elhassani
Keywords
Related Articles
- EP ID EP673242
- DOI -
- Views 128
- Downloads 0
SELF MEDICATION IN MEDICAL STUDENTS OF ALLAMA IQBAL MEDICAL COLLEGE
Background: Self-medication is practiced significantly worldwide even though its types, extent and reasons vary. This research was conducted to describe and evaluate the medicines used by medical students, awareness, rea...
PHARMACOLOGICAL ASPECT OF ARTEMISININ AND ARESUNATE AS POTENT ANTI MALARIAL AGENTS - OVERVIEW
Artemisinin (ARN) is a natural anti-malarial product which can be isolated from the Chinese medicinal herb Artemisia annua. It comprises a new generation of antimalarial compounds that feature a nitrogenfree sesquiterpen...
CHEMICAL ABSTRACTS SERVICE: THE GOLD STANDARD FOR CHEMICAL SUBSTANCE INFORMATION
A chemical is a form of matter that has constant chemical composition and characteristic properties. It cannot be separated into components by physical separation methods, i.e., without breaking chemical bonds. Chemical...
BIOAVAILABILITY AND BIOEQUIVALENCE EVALUATION OF LOKMAL® (ARTEMETHER-LUMEFANTRINE 80/480 MG FIXED DOSE TABLET): AN EMZOR® PHARMACEUTICAL PRODUCT
Present design evaluated the bioavailability and bioequivalence of generic product of artemether - lumefantrine (AL) antimalarial fixed dose tablet which presents as Lokmal® 80/480 mg an Emzor® Pharmaceutical brand formu...
GENERAL PUBLIC AWARENESS ABOUT SYMPTOMS AND RISK FACTORS OF SOME CARDIOVASCULAR DISEASES IN KSA, RIYADH 2017
Background: Cardiovascular diseases is considered the most common cause of death in the world; it is the cause of about 50% of deaths in the world, and it’s expected to increase significantly. Cardiovascular diseases is...